Kevin McCulloch

Insider Reports History

Entity
Individual
Location
Xeris Biopharma Holdings, Inc., 1375 West Fulton Street, Suite 1300, Chicago, IL
Signature
/s/ Beth Hecht, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kevin McCulloch:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Xeris Biopharma Holdings, Inc. President and Chief Operating Officer Common Stock 1.68M $8.67M $5.15 Apr 2, 2025 Direct
Xeris Biopharma Holdings, Inc. President and Chief Operating Officer Common Stock 25K $129K $5.15 Apr 2, 2025 By Spouse
Xeris Biopharma Holdings, Inc. President and Chief Operating Officer Common Stock 2K $10.3K $5.15 Apr 2, 2025 By Charles R. McCulloch Trust dated 1990
Xeris Biopharma Holdings, Inc. President and Chief Operating Officer Stock Appreciation Right 500K Jan 31, 2025 Direct

Insider Reports Filed by Kevin McCulloch

Symbol Company Period Transactions Value $ Form Type Date Filed Role
XERS Xeris Biopharma Holdings, Inc. Apr 2, 2025 1 -$3.77K 4 Apr 3, 2025 President and Chief Operating Officer
XERS Xeris Biopharma Holdings, Inc. Jan 31, 2025 4 -$278K 4 Feb 3, 2025 President and Chief Operating Officer
XERS Xeris Biopharma Holdings, Inc. Jan 3, 2025 1 -$88.4K 4 Jan 7, 2025 President and Chief Operating Officer
XERS Xeris Biopharma Holdings, Inc. Aug 1, 2024 2 $0 4 Aug 2, 2024 President and Chief Operating Officer
XERS Xeris Biopharma Holdings, Inc. Aug 1, 2024 0 $0 3 Aug 2, 2024 President and Chief Operating Officer